Agrifields hosts health camp
The health initiative included a door-to-door awareness drive followed by a full-day medical camp, benefiting over 200 villagers. Free screenings were conducted for blood pressure, sugar levels, and general wellness.
Doctors provided consultations, medicines, and nutrition advice at free of cost.
'Many villagers learned of health issues for the first time. We began their treatment immediately,' said Amit Gupta, Co-Founder & CEO of Agrifields.
In parallel, Agrifields supported a vibrant sports and academic celebration at Zilla Parishad High School, Rellivalasa. Over 250 students participated in games like kabaddi and kho-kho. Prizes were distributed to winners, and cash awards were given to five top-performing students, including a girl who lost both parents, in a gesture of encouragement.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
2 days ago
- Time of India
Faecal coliform at Gaurikund, gateway to Kedar, way above safe limit: RTI
Dehradun: The faecal coliform (FC) level at a drain in Gaurikund, starting point of the Kedarnath trek, was found to be 4.9 million MPN/100ml, far exceeding the Central Pollution Control Board's (CPCB) permissible limit of 2,500 MPN/100ml. The data was disclosed by CPCB in response to an RTI filed by a Noida-based activist. Experts attributed the pollution to lack of a sewage treatment plant (STP) and a rise in pilgrim numbers in recent years. Over 14 lakh pilgrims have already visited Kedarnath this season, shows govt data. Vishal Singh, executive director of Centre for Ecology Development and Research called for capping visitor numbers to limit organic waste in the region. CPCB said there are two drains each in Kedarnath Dham and Gaurikund with two untapped drains flowing into the Mandakini and Saraswati rivers. "At the drain at the entrance of the pedestrian yatra, near the Gaurikund police post, the BOD (biochemical oxygen demand) was recorded at 184 mg/l (the limit for drinking water is less than 5, and for treated wastewater, up to 30), COD (chemical oxygen demand) at 362 mg/l (permissible limit: 250), and FC at 4.9 million (desirable limit: 500, permissible: 2,500)," stated the RTI reply in response to queries posed by Amit Gupta. "Pollution level at Gaurikund is dangerously high, suggesting heavy sewage inflow, untreated waste, and health-threatening pathogens. This kind of contamination not only harms river ecosystems downstream but also threatens spring sources, which supply potable water, support agriculture, and sustain tourism. Poor sewage management, coupled with warming in the high Himalayas, will affect biodiversity and increase disease risks by creating breeding grounds for vectors like mosquitoes," said Singh. He also stressed the need to prioritise sewage treatment infrastructure in such ecologically sensitive areas. "Strict regulations for solid and liquid waste management must be enforced, and water quality monitoring strengthened. Behavioural change is also key and awareness drives should be launched across the Char Dham route. Eco-sensitive pilgrim infrastructure is essential to protect these fragile high-altitude ecosystems and ensure clean water for communities," he said. The STP in Kedarnath, which was scheduled for completion before the 2025 yatra season, remains unfinished. Officials had earlier said it would be ready by May 30. In an affidavit to National Green Tribunal (NGT) in April, Rudraprayag district magistrate Saurabh Gaharwar said the original deadline was Dec 2024, later revised to Dec 14, 2025, for full system connectivity. Currently, all untreated sewage continues to be discharged into the Mandakini river due to the absence of a functional STP. NGT had pulled up both the Rudraprayag administration and the Uttarakhand Pollution Control Board (UKPCB) for failing to act on environmental violations. The DM's affidavit had claimed that 85% of STP construction was complete. Even if completed by year-end, environmentalists have raised concerns over the plant's limited capacity of 600 KLD (kilolitres per day). A petitioner pointed out that the design considered a permanent population of 5,000 and a floating population of 20,000 – a number regularly exceeded during the yatra. Following the RTI revelations, UKPCB has asked the public works department (PWD) to explore increasing the proposed STP capacity. "Construction is being carried out under the Kedarnath Dham masterplan…However, many toilets outside the masterplan boundary are also being used by pilgrims. The nodal department needs to address these as well," wrote Vinay Jhinkwan, executive engineer, PWD, in a letter to the officer at special duty (OSD) of the Kedarnath Charitable Trust.
Hindustan Times
2 days ago
- Hindustan Times
Why access to stem cell transplants is out of reach for many thalassemia patients in India
India carries the world's most significant burden of thalassemia, with an estimated 150,000 patients and 12,000 new cases every year. While medical science continues to advance and success rates after hematopoietic stem cell transplants (HSCT) have increased globally as a potential cure for thalassemia, far too many Indian families still lack access to this life-saving treatment. The barriers are not just medical, but they are deeply rooted in systemic inequities, beginning with the first step—Human Leukocyte Antigen (HLA). Thalassemia HLAs are proteins on the surface of cells that play a crucial role in the body's immune system. They act like identification tags, allowing the immune system to distinguish between the body's cells and foreign invaders, such as bacteria or viruses. Managing thalassemia requires lifelong care that puts patient and their family into an immense financial hardship. Patients undergo regular blood transfusions and iron chelation therapy. India is the thalassemia capital of the world, with a thalassemia burden of around 150,000 patients and an incidence of approximately 12,000 every year. The recurring cost of ongoing optimal patient management varies between ₹100,000 and ₹120,000 per year. This is not affordable for most Indian families, as the estimated per capita Net National Income (NNI) of India is ₹126,000 ($ 1732). The permanent curative treatment option of HSCT is not well known in India. However, current experience worldwide indicates that more than 90% of patients now survive HSCT, and disease-free survival rates are around 80%. A significant challenge to accessing blood stem cell transplant is the associated costs, as most of the payment for HSCT is out of pocket. The Indian government is supporting ongoing patient needs through a national-level blood safety policy and the institutionalisation of state-level blood availability for patients' monthly blood transfusions and iron chelation medicines. It is also encouraging the public and private sectors to support transplant costs for poor patients as Corporate Social Responsibility (CSR) initiatives. Some states have state-level schemes to help patients with thalassemia and HSCT expenses. Thus, eligible poor patients opting for an HSCT can avail themselves of funding support from Government schemes, CSR funds, and other donations. However, these funds do not cover the costs of high-resolution HLA typing, which is the initial step in the medical assessment for an HSCT. Several global and national non-profit organisations—working towards giving patients suffering from thalassemia a second chance at life—have launched initiatives to address this gap. The initiatives include free or subsidised high-re HLA typing for families from low-income backgrounds. Such programmes are designed to enable transplant centres, NGOs, and hospitals to work in close collaboration across India. Through these initiatives, tools such as awareness drives and campaigns have also been conducted in urban and semi-urban areas to educate families about the potential cure and facilitate early intervention. These efforts have led to thousands of families receiving free HLA typing, and in numerous--instances, access to donor searches through worldwide stem cell registries when no familial match was found. We have also adopted collaborative models that not only assist Indian patients but also extend support to neighbouring countries, such as Sri Lanka, Bangladesh, and the Maldives, demonstrating the regional need for cross-border medical cooperation. Despite this advancement, large-scale systemic difficulties persist. Transplants are resource-intensive procedures that necessitate robust infrastructure, a diverse donor registry pool, donor availability, and post-transplant care. All of which demand significant public health investment. Without the wide-ranging inclusion of diagnostic tools, such as high-res HLA typing and blood stem cell transplants, in government-funded healthcare plans, treatment remains a luxury for the few rather than a right for all. The cost of a match should not be borne only by the patient or their family. It must be viewed as a shared responsibility across sectors, including government, healthcare institutions, civil society, and corporate partners alike. Only then can equitable access to curative options and care become a grounded reality for every child born with thalassemia, regardless of their socio-economic background. This article is authored by Dr Nitin Agarwal, MD, Transfusion Medicine, HOD-Donor Request Management, DKMS Foundation India.
Hans India
3 days ago
- Hans India
ONGC to fund cancer infrastructure in three hospitals
Kakinada: Oil and Natural Gas Corporation (ONGC) has agreed to provide financial support for the installation of advanced radiation machines for cancer treatment at government hospitals in Kakinada, Guntur, and Kadapa districts. The initiative, costing Rs 48 crore, will be funded under ONGC's Corporate Social Responsibility (CSR) programme. The decision was taken following a meeting between Union Minister for Petroleum and Natural Gas Hardeep Singh Puri and a delegation comprising Dr P Chandrasekhar, Union Minister of State for Rural Development and Communications, and Rajya Sabha MP Sana Satish Babu. During the meeting held in New Delhi on Thursday, the leaders sought central assistance in strengthening the fight against cancer in Andhra Pradesh. Speaking to 'The Hans India', MP Satish Babu said that the proposal involved the procurement of three state-of-the-art radiation therapy machines, each worth approximately Rs 16 crore. Minister Puri responded positively and initiated discussions with ONGC officials, leading to the company's commitment to provide the equipment. He also said that these machines will play a crucial role in the early detection and effective radiation treatment of cancer. The equipment will soon be installed at the respective government hospitals, significantly enhancing oncology infrastructure and care in the region.
